Shanghai RAAS Blood Products Co Ltd Class A (002252) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.026x

Based on the latest financial reports, Shanghai RAAS Blood Products Co Ltd Class A (002252) has a cash flow conversion efficiency ratio of -0.026x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-843.75 Million ≈ $-123.47 Million USD) by net assets (CN¥32.46 Billion ≈ $4.75 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 002252 defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Shanghai RAAS Blood Products Co Ltd Class A - Cash Flow Conversion Efficiency Trend (2005–2025)

This chart illustrates how Shanghai RAAS Blood Products Co Ltd Class A's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Shanghai RAAS Blood Products Co Ltd Class A Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shanghai RAAS Blood Products Co Ltd Class A ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Wacker Chemie AG XETRA:WCH	0.020x
Boot Barn Holdings Inc NYSE:BOOT	0.163x
FTI Consulting Inc NYSE:FCN	-0.187x
Knife River Corporation NYSE:KNF	-0.038x
Ecovacs Robotics Co Ltd SHG:603486	0.054x
COCHLEAR LTD ADR 1/2/O.N. F:OC50	N/A
Scholar Rock Holding Corp NASDAQ:SRRK	-0.281x
Spirit Aerosystems Holdings Inc NYSE:SPR	0.041x

Annual Cash Flow Conversion Efficiency for Shanghai RAAS Blood Products Co Ltd Class A (2005–2025)

The table below shows the annual cash flow conversion efficiency of Shanghai RAAS Blood Products Co Ltd Class A from 2005 to 2025. For the full company profile with market capitalisation and key ratios, see 002252 market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥32.47 Billion ≈ $4.75 Billion	CN¥-104.89 Million ≈ $-15.35 Million	-0.003x	+78.59%
2024-12-31	CN¥31.94 Billion ≈ $4.67 Billion	CN¥-482.06 Million ≈ $-70.54 Million	-0.015x	-119.64%
2023-12-31	CN¥29.65 Billion ≈ $4.34 Billion	CN¥2.28 Billion ≈ $333.33 Million	0.077x	+28.28%
2022-12-31	CN¥28.81 Billion ≈ $4.22 Billion	CN¥1.73 Billion ≈ $252.51 Million	0.060x	+19.89%
2021-12-31	CN¥25.90 Billion ≈ $3.79 Billion	CN¥1.29 Billion ≈ $189.35 Million	0.050x	+7.40%
2020-12-31	CN¥25.13 Billion ≈ $3.68 Billion	CN¥1.17 Billion ≈ $171.04 Million	0.047x	-38.76%
2019-12-31	CN¥11.49 Billion ≈ $1.68 Billion	CN¥872.69 Million ≈ $127.70 Million	0.076x	+215.35%
2018-12-31	CN¥10.90 Billion ≈ $1.60 Billion	CN¥262.50 Million ≈ $38.41 Million	0.024x	+11.83%
2017-12-31	CN¥12.48 Billion ≈ $1.83 Billion	CN¥268.76 Million ≈ $39.33 Million	0.022x	-60.42%
2016-12-31	CN¥11.73 Billion ≈ $1.72 Billion	CN¥638.22 Million ≈ $93.39 Million	0.054x	-23.55%
2015-12-31	CN¥10.71 Billion ≈ $1.57 Billion	CN¥762.42 Million ≈ $111.57 Million	0.071x	+31.73%
2014-12-31	CN¥8.62 Billion ≈ $1.26 Billion	CN¥465.96 Million ≈ $68.18 Million	0.054x	+166.06%
2013-12-31	CN¥1.10 Billion ≈ $161.22 Million	CN¥-90.11 Million ≈ $-13.19 Million	-0.082x	-131.65%
2012-12-31	CN¥1.02 Billion ≈ $149.18 Million	CN¥263.46 Million ≈ $38.55 Million	0.258x	+34.61%
2011-12-31	CN¥927.27 Million ≈ $135.69 Million	CN¥178.03 Million ≈ $26.05 Million	0.192x	-20.29%
2010-12-31	CN¥831.21 Million ≈ $121.63 Million	CN¥200.21 Million ≈ $29.30 Million	0.241x	+58.49%
2009-12-31	CN¥763.33 Million ≈ $111.70 Million	CN¥116.01 Million ≈ $16.98 Million	0.152x	+6.57%
2008-12-31	CN¥754.76 Million ≈ $110.45 Million	CN¥107.64 Million ≈ $15.75 Million	0.143x	-86.20%
2007-12-31	CN¥170.01 Million ≈ $24.88 Million	CN¥175.71 Million ≈ $25.71 Million	1.034x	+202.38%
2006-12-31	CN¥156.77 Million ≈ $22.94 Million	CN¥53.58 Million ≈ $7.84 Million	0.342x	+46.61%
2005-12-31	CN¥231.70 Million ≈ $33.90 Million	CN¥54.02 Million ≈ $7.90 Million	0.233x	--

About Shanghai RAAS Blood Products Co Ltd Class A

SHE:002252 China Biotechnology

Market Cap

$4.65 Billion

CN¥31.80 Billion CNY

Market Cap Rank

#3800 Global

#582 in China

Share Price

CN¥4.79

Change (1 day)

-2.84%

52-Week Range

CN¥4.79 - CN¥7.18

All Time High

CN¥24.72